22bet weekly bonus
NoneThe Chicago Blackhawks blew a two-goal lead in the third period and lost to the host Philadelphia Flyers 2-0 in overtime Saturday. The loss wasted standout performances by goalie Petr Mrázek as well as fourth-liners Lukas Reichel, Pat Maroon and Craig Smith, who produced two goals and essentially dominated Flyers top threat Travis Konecny and his line. The Hawks’ penchant for throttling down in the third period did them in and cost them a chance to win in regulation. The Flyers seized the momentum in the third, knotting it 2-2 on goals by Sean Couturier and Noah Cates. Alex Vlasic committed a holding penalty in overtime, and rookie Matvei Michkov scored the winner at 1:06. The Flyers became one of just 11 teams to win after staging a third-period, multigoal comeback. The Hawks, who beat the defending Stanley Cup champion Florida Panthers 3-1 on Thursday, lost for the fourth time in five games. “We got the lead and just costly turnovers,” Maroon said. “They played a good game, they stuck with their structure. ... “We’ve got to be better. (It’s) a 60-minute game, and unfortunately, we maybe played 20 of it.” Entering the game, the Reichel line had a 52% shots-for advantage in five-on-five and outscored opponents 3-1, according to naturalstattrick.com. On Saturday, they outshot opponents 8-5. On the opening goal, Maroon made a pass to Reichel, who flushed it with a sharp-angle shot for his first goal in 10 games at 11:29 of the first. In the second period, Maroon took a low-to-high feed from Smith and backhanded it past Aleksei Kolosov for his first goal as a Hawk. Reichel also assisted. But for the Hawks to even be in it, it took some stunning saves from Mrázek, who finished with 34 saves, particularly in the first period. Blackhawks goalie Petr Mrazek, left, blocks a shot by the Flyers’ Sean Couturier during the second period on Nov. 23, 2024, in Philadelphia. Mrazek made 34 saves in the 3-2 overtime loss. (Matt Slocum/AP) His 10 stops in the opening frame include his calm against a short-handed two-on-none rush between Konecny and Scott Laughton. Konecny tried to set up Laughton for a close-range tip-in, but Mrázek stretched to knock it away with his pad. In the third, Konecny back-passed to Morgan Frost for a Grade A point-blank chance, but Mrázek swallowed it up. During a frenetic Flyers attack, Mrázek preserved the tie with a diving stop on a wraparound by Rasmus Ristolainen. To put the Hawks goalie’s game in perspective, the Flyers held a 17-7 advantage in high-danger chances.
U.S. Home Infusion Therapy Market Set for Exceptional Growth in the Forecast 2024-2032 12-27-2024 07:11 PM CET | Health & Medicine Press release from: Cognate Insights U.S. Home Infusion Therapy Market Latest Market Overview The U.S. home infusion therapy market is expected to reach USD 22.5 billion by 2024, with a compound annual growth rate (CAGR) of 9.1% from 2024 to 2032. Home infusion therapy involves the administration of intravenous (IV) medications at home, including antibiotics, chemotherapy drugs, and biologics, under the supervision of healthcare professionals. With the increasing prevalence of chronic diseases, the aging population, and the growing preference for home-based healthcare, the market is experiencing significant growth. The shift from hospital-based care to home care is a major driver for the expansion of this market. The U.S. Home Infusion Therapy Market has experienced steady growth in recent years and is expected to continue expanding at a strong pace from 2024 to 2032. This analysis offers a comprehensive overview, providing valuable insights into key trends and developments within the U.S. Home Infusion Therapy industry. These findings equip business leaders with the necessary knowledge to devise more effective strategies and enhance profitability. Furthermore, the report serves as a useful resource for new and emerging businesses, helping them make informed decisions as they navigate the market and seek growth opportunities. Major Players of U.S. Home Infusion Therapy Market are: Option Care Health, Inc. - Bannockburn, IL (Revenue: USD 3.73 billion in 2023) CVS Health Corporation - Woonsocket, RI (Revenue: USD 5.6 billion from specialty pharmacy division in 2023) B. Braun Medical Inc. - Bethlehem, PA (Revenue: USD 1.8 billion in 2023) CareCentrix, Inc. - Hartford, CT (Revenue: USD 2.1 billion in 2023) Get Latest PDF Sample Report @ https://www.cognateinsights.com/request-sample/us-home-infusion-therapy-market Our Report covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2032 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets. Global U.S. Home Infusion Therapy Market Landscape and Future Pathways: North America: United States Canada Europe: Germany France U.K. Italy Russia Asia-Pacific: China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America: Mexico Brazil Argentina Korea Colombia Middle East & Africa: Turkey Saudi Arabia UAE Korea Speak to Our Analyst for A Discussion on The Above Findings, And Ask for A Discount on The Report @ https://www.cognateinsights.com/check-discount/us-home-infusion-therapy-market Key drivers and challenges influencing the U.S. Home Infusion Therapy market: Regional Analysis: The report involves examining the U.S. Home Infusion Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets. Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the U.S. Home Infusion Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends. Company Analysis: Report covers individual U.S. Home Infusion Therapy manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies. Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards U.S. Home Infusion Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application. Technology Analysis: Report covers specific technologies relevant to U.S. Home Infusion Therapy. It assesses the current state, advancements, and potential future developments in U.S. Home Infusion Therapy areas. Reason to Buy this Report: -Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years. -Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants. -Overview of the competitive landscape in the U.S. Home Infusion Therapy market, including profiles of the key players, their market share, and strategies for growth. -Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth. -Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants. For In-Depth Competitive Analysis - Purchase this Report now at @ https://www.cognateinsights.com/purchase-report/us-home-infusion-therapy-market Contact Us: Cognate Insights Web: www.cognateinsights.com Email: info@cognateinsights.com Phone: +91 8424946476 About Us: We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy. This release was published on openPR.
AP Sports SummaryBrief at 6:06 p.m. ESTThe Biden administration has imposed sanctions on the founder of Georgia’s ruling political party, which has steered the country away from a pro-Western stance and towards Russia, US officials said. The US State and Treasury departments said they hit Georgian Dream party founder and honorary chairman Bidzina Ivanishvili with penalties “for undermining the democratic and Euro-Atlantic future of Georgia for the benefit of the Russian Federation”, according to a statement. The designation of Mr Ivanishvili is the latest in a series of sanctions the US has placed on Georgian politicians and others this year. Those sanctions include freezes on assets and properties those targeted may have in US jurisdictions or that might enter US jurisdictions as well as travel bans on the targets and members of their families. “We strongly condemn Georgian Dream’s actions under Ivanishvili’s leadership, including its ongoing and violent repression of Georgian citizens, protesters, members of the media, human rights activists, and opposition figures,” the State Department said in a statement. “The United States is committed to promoting accountability for those undermining democracy and human rights in Georgia.” Mr Ivanishvili is a billionaire who made his fortune in Russia and served briefly as Georgia’s prime minister. In 2012, he founded Georgian Dream, Georgia’s longtime ruling party. Critics have accused Georgian Dream of becoming increasingly authoritarian and tilted towards Moscow. The party recently pushed through laws similar to those used by the Kremlin to crack down on freedom of speech and LGBT+ rights, prompting the European Union to suspend Georgia’s membership application process indefinitely. In October, Georgian Dream won another term in a divisive parliamentary election that has led to more mass protests. Last month, the country’s prime minister, Irakli Kobakhidze, announced a four-year suspension of talks on Georgia’s bid to join the European Union, fuelling further public outrage.